Skip to main content
  1. Market Insights
  2. Health
  3. Pharmaceuticals

Other Pharmaceuticals - India

India
  • The Other Pharmaceuticals market in India is expected to witness a significant surge in revenue, with projections indicating a substantial increase to reach ₹US$4.38bn by the year 2024.
  • Furthermore, it is anticipated that the market will experience consistent growth, with an annual growth rate (CAGR 2024-2029) of 4.56%.
  • This growth trajectory is expected to result in a market volume of ₹US$5.48bn by 2029.
  • When compared to other countries on a global scale, United States is projected to generate the highest revenue in the Other Pharmaceuticals market, with an estimated value of US$260.50bn in the year 2024.
  • India's pharmaceutical market is booming, with a growing demand for alternative and traditional medicines in the Other Pharmaceuticals market.

Definition:
The market Other Pharmaceuticals covers revenues for areas that are not specifically mentioned in the other markets, such as psychotropic or gastroenterology drugs and less expensive but widely used drugs, such as cold and cough remedies or analgesics.

Additional information:
Market values represent the revenues generated by manufacture prices paid to primary vendors, either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), companies (B2B), and governments (B2G).

In-Scope

  • Psychotropic drugs
  • Gastroenterology
  • Cold and cough remedies
  • Antibiotics
  • Women's health
  • Analgesics

Out-Of-Scope

  • Veterinary drugs
  • Medical devices
Pharmaceuticals: market data & analysis - Cover

Market Insights report

Pharmaceuticals: market data & analysis

Study Details

    Revenue

    Notes: Data shown is using current exchange rates and reflects market impacts of the Russia-Ukraine war.

    Most recent update: Jun 2024

    Source: Statista Market Insights

    Notes: The chart “Comparable Estimates” shows the forecasted development of the selected market from different sources. Please see the additional information for methodology and publication date.

    Most recent update: Mar 2024

    Analyst Opinion

    The Other Pharmaceuticals market in India has been experiencing significant growth in recent years.

    Customer preferences:
    Customers in India have been increasingly seeking out alternative forms of medicine, such as Ayurveda and homeopathy. This has led to a rise in demand for Other Pharmaceuticals, which includes herbal and natural remedies.

    Trends in the market:
    The Other Pharmaceuticals market in India has been growing rapidly due to the increasing popularity of natural and herbal remedies. This trend has been driven by a growing awareness of the potential health benefits of these products, as well as a desire for more sustainable and eco-friendly options. In addition, the Indian government has been promoting the use of alternative medicine through various initiatives and policies.

    Local special circumstances:
    India has a rich tradition of Ayurveda and other traditional forms of medicine, which has contributed to the popularity of natural and herbal remedies. In addition, the country has a large population that is increasingly health-conscious and willing to try new products and treatments.

    Underlying macroeconomic factors:
    The growth of the Other Pharmaceuticals market in India is also being driven by a number of underlying macroeconomic factors. These include a growing middle class with higher disposable incomes, increasing urbanization, and a rising demand for healthcare products and services. In addition, the Indian government has been investing heavily in the healthcare sector, which is expected to further boost demand for Other Pharmaceuticals in the coming years.

    Next generation therapy

    Notes: Data shown is using current exchange rates and reflects market impacts of the Russia-Ukraine war.

    Most recent update: Sep 2024

    Source: Statista Market Insights

    Global Comparison

    Most recent update: Jun 2024

    Source: Statista Market Insights

    Methodology

    Data coverage:

    Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

    Modeling approach / Market size:

    Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

    Forecasts:

    In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

    Additional notes:

    Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.

    Health

    Access more Market Insights on Health topics with our featured report

    Pharmaceuticals: market data & analysis - BackgroundPharmaceuticals: market data & analysis - Cover

    Key Market Indicators

    Notes: Based on data from IMF, World Bank, UN and Eurostat

    Most recent update: Sep 2024

    Source: Statista Market Insights

    Explore more high-quality data on related topic

    Global pharmaceutical industry - statistics & facts

    The pharmaceutical industry is responsible for the research, development, production, and distribution of medications. The market has experienced significant growth during the past two decades, and pharma revenues worldwide totaled 1.48 trillion U.S. dollars in 2022.
    More data on the topic

    Contact

    Get in touch with us. We are happy to help.